Next Generation Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066635
  • May 2021
  • Biotechnology
  • 141 Pages
The Next Generation Cancer Diagnostics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Koninklijke Philips N.V., Agilent Technologies, Inc., Biospherex LLC, Cepheid, F. Hoffmann-La Roche Ltd, General Electric Co., Lunaphore Technologies S.A., QIAGEN N.V, Thermo Fisher Scientific Inc., Abbott
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Next Generation Cancer Diagnostics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Next Generation Cancer Diagnostics market is expected to attain Pre COVID-19 levels by mid-2022.

Next Generation Cancer Diagnostics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Next Generation Cancer Diagnostics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Next Generation Cancer Diagnostics Market Competitive and Premeditated Analysis
In the Next Generation Cancer Diagnostics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Next Generation Cancer Diagnostics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Next Generation Cancer Diagnostics Market:
The Next Generation Cancer Diagnostics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Koninklijke Philips N.V., Agilent Technologies, Inc., Biospherex LLC, Cepheid, F. Hoffmann-La Roche Ltd, General Electric Co., Lunaphore Technologies S.A., QIAGEN N.V, Thermo Fisher Scientific Inc., Abbott

The Next Generation Cancer Diagnostics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Next Generation Cancer Diagnostics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Next Generation Cancer Diagnostics market:
By Technology
qPCR and Multiplexing
Benchtop Sequencers
Lab-on-a-chip
Next Generation Sequencing
Protein Microarrays
DNA Microarrays
Other Technologies
Application
Biomarker Development
Proteomic Analysis
CTC Analysis
Genetic Analysis
Epigenetic Analysis
Cancer Type
Lung Cancer
Colorectal Cancer
Breast Cancer
Prostate Cancer
Others
Function
Cancer Screening
Therapeutic Monitoring
Prognosis Diagnostics
Risk Analysis
Companion Diagnostics

Regional Analysis of the Next Generation Cancer Diagnostics market:
The Next Generation Cancer Diagnostics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Next Generation Cancer Diagnostics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Next Generation Cancer Diagnostics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Next Generation Cancer Diagnostics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Next Generation Cancer Diagnostics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Next Generation Cancer Diagnostics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Next Generation Cancer Diagnostics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Next Generation Cancer Diagnostics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Next Generation Cancer Diagnostics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Next Generation Cancer Diagnostics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Koninklijke Philips N.V.
  • Agilent Technologies, Inc.
  • Biospherex LLC
  • Cepheid
  • F. Hoffmann-La Roche Ltd
  • General Electric Co.
  • Lunaphore Technologies S.A.
  • QIAGEN N.V
  • Thermo Fisher Scientific Inc.
  • Abbott
  • qPCR and Multiplexing
  • Benchtop Sequencers
  • Lab-on-a-chip
  • Next Generation Sequencing
  • Protein Microarrays
  • DNA Microarrays
  • Other Technologies
  • Cancer Screening
  • Therapeutic Monitoring
  • Prognosis Diagnostics
  • Risk Analysis
  • Companion Diagnostics

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Next Generation Cancer Diagnostics Market Snapshot
          2.1.1. Global Next Generation Cancer Diagnostics Market By Technology,2019
               2.1.1.1.qPCR and Multiplexing
               2.1.1.2.Benchtop Sequencers
               2.1.1.3.Lab-on-a-chip
               2.1.1.4.Next Generation Sequencing
               2.1.1.5.Protein Microarrays
               2.1.1.6.DNA Microarrays
               2.1.1.7.Other Technologies
          2.1.2. Global Next Generation Cancer Diagnostics Market By Function,2019
               2.1.2.1.Cancer Screening
               2.1.2.2.Therapeutic Monitoring
               2.1.2.3.Prognosis Diagnostics
               2.1.2.4.Risk Analysis
               2.1.2.5.Companion Diagnostics
          2.1.3. Global Next Generation Cancer Diagnostics Market By End-use,2019
          2.1.4. Global Next Generation Cancer Diagnostics Market By Geography,2019

3. Global Next Generation Cancer Diagnostics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028

5. Global Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Function, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Function, 2020
     5.2. Global Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028

6. Global Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028

7. Global Next Generation Cancer Diagnostics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Next Generation Cancer Diagnostics Market Analysis, 2018 – 2028 
          7.2.1. North America Next Generation Cancer Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028
          7.2.4. North America Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Next Generation Cancer Diagnostics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Next Generation Cancer Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028
          7.3.4. Europe Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Next Generation Cancer Diagnostics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Next Generation Cancer Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028
          7.4.4. Asia Pacific Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Next Generation Cancer Diagnostics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Next Generation Cancer Diagnostics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028
          7.5.4. Latin America Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Next Generation Cancer Diagnostics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Next Generation Cancer Diagnostics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Next Generation Cancer Diagnostics Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Next Generation Cancer Diagnostics Market Size (US$), By Function, 2018 – 2028
          7.6.4. MEA Next Generation Cancer Diagnostics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Next Generation Cancer Diagnostics Providers
        8.4.1 Koninklijke Philips N.V.
                8.4.1.1 Business Description
                8.4.1.2 Koninklijke Philips N.V. Geographic Operations
                8.4.1.3 Koninklijke Philips N.V. Financial Information
                8.4.1.4 Koninklijke Philips N.V. Product Positions/Portfolio
                8.4.1.5 Koninklijke Philips N.V. Key Developments
        8.4.2 Agilent Technologies, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Agilent Technologies, Inc. Geographic Operations
                8.4.2.3 Agilent Technologies, Inc. Financial Information
                8.4.2.4 Agilent Technologies, Inc. Product Positions/Portfolio
                8.4.2.5 Agilent Technologies, Inc. Key Developments
        8.4.3 Biospherex LLC
                8.4.3.1 Business Description
                8.4.3.2 Biospherex LLC Geographic Operations
                8.4.3.3 Biospherex LLC Financial Information
                8.4.3.4 Biospherex LLC Product Positions/Portfolio
                8.4.3.5 Biospherex LLC Key Developments
        8.4.4 Cepheid
                8.4.4.1 Business Description
                8.4.4.2 Cepheid Geographic Operations
                8.4.4.3 Cepheid Financial Information
                8.4.4.4 Cepheid Product Positions/Portfolio
                8.4.4.5 Cepheid Key Developments
        8.4.5 F. Hoffmann-La Roche Ltd
                8.4.5.1 Business Description
                8.4.5.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.5.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.5.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.5.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.6 General Electric Co.
                8.4.6.1 Business Description
                8.4.6.2 General Electric Co. Geographic Operations
                8.4.6.3 General Electric Co. Financial Information
                8.4.6.4 General Electric Co. Product Positions/Portfolio
                8.4.6.5 General Electric Co. Key Developments
        8.4.7 Lunaphore Technologies S.A.
                8.4.7.1 Business Description
                8.4.7.2 Lunaphore Technologies S.A. Geographic Operations
                8.4.7.3 Lunaphore Technologies S.A. Financial Information
                8.4.7.4 Lunaphore Technologies S.A. Product Positions/Portfolio
                8.4.7.5 Lunaphore Technologies S.A. Key Developments
        8.4.8 QIAGEN N.V
                8.4.8.1 Business Description
                8.4.8.2 QIAGEN N.V Geographic Operations
                8.4.8.3 QIAGEN N.V Financial Information
                8.4.8.4 QIAGEN N.V Product Positions/Portfolio
                8.4.8.5 QIAGEN N.V Key Developments
        8.4.9 Thermo Fisher Scientific Inc.
                8.4.9.1 Business Description
                8.4.9.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.9.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.9.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.9.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.10 Abbott
                8.4.10.1 Business Description
                8.4.10.2 Abbott Geographic Operations
                8.4.10.3 Abbott Financial Information
                8.4.10.4 Abbott Product Positions/Portfolio
                8.4.10.5 Abbott Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Next Generation Cancer Diagnostics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Next Generation Cancer Diagnostics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Next Generation Cancer Diagnostics Market Revenue, By Function, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Next Generation Cancer Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Next Generation Cancer Diagnostics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Next Generation Cancer Diagnostics Market Revenue, By Function, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Next Generation Cancer Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Next Generation Cancer Diagnostics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Next Generation Cancer Diagnostics Market Revenue, By Function, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Next Generation Cancer Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Next Generation Cancer Diagnostics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Next Generation Cancer Diagnostics Market Revenue, By Function, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Next Generation Cancer Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Next Generation Cancer Diagnostics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Next Generation Cancer Diagnostics Market Revenue, By Function, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Next Generation Cancer Diagnostics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Next Generation Cancer Diagnostics: Market Segmentation 
FIG. 2 Global Next Generation Cancer Diagnostics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Next Generation Cancer Diagnostics Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Next Generation Cancer Diagnostics Market, By Function, 2019 (US$ Mn) 
FIG. 6 Global Next Generation Cancer Diagnostics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Next Generation Cancer Diagnostics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Next Generation Cancer Diagnostics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Next Generation Cancer Diagnostics Providers, 2019
FIG. 11 Global Next Generation Cancer Diagnostics Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Next Generation Cancer Diagnostics Market Revenue Contribution, By Function, 2019 & 2028 (Value %) 
FIG. 13 Global Next Generation Cancer Diagnostics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Next Generation Cancer Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Next Generation Cancer Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Next Generation Cancer Diagnostics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Next Generation Cancer Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Next Generation Cancer Diagnostics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Next Generation Cancer Diagnostics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Next Generation Cancer Diagnostics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Next Generation Cancer Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  North America Next Generation Cancer Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  North America Next Generation Cancer Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Europe Next Generation Cancer Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Next Generation Cancer Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Next Generation Cancer Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Next Generation Cancer Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Next Generation Cancer Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Next Generation Cancer Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Latin America Next Generation Cancer Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Next Generation Cancer Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Next Generation Cancer Diagnostics Market Value, By Country, 2018 – 2028
TABLE  MEA Next Generation Cancer Diagnostics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Next Generation Cancer Diagnostics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Next Generation Cancer Diagnostics Market Value, By Country, 2018 – 2028
TABLE  Koninklijke Philips N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent Technologies, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biospherex LLC: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cepheid: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  General Electric Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lunaphore Technologies S.A.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  QIAGEN N.V: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Next Generation Cancer Diagnostics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Next Generation Cancer Diagnostics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Next Generation Cancer Diagnostics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Next Generation Cancer Diagnostics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Next Generation Cancer Diagnostics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Next Generation Cancer Diagnostics Providers, 2016
FIG.  Global Next Generation Cancer Diagnostics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Benchtop Sequencers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Lab-on-a-chip Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Next Generation Sequencing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Protein Microarrays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global DNA Microarrays Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Other Technologies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Next Generation Cancer Diagnostics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Therapeutic Monitoring Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Prognosis Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Risk Analysis Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Companion Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Next Generation Cancer Diagnostics Market Value, 2018 – 2028, (US$ Mn)